Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G. Crystal

Showing results (171-180 of 509) with videos related to

Pageof 51
Sort By:
Current Opinion in Molecular Therapeutics|March 16, 2001
Antivector and antitransgene host responses in gene therapyN R Hackett, S M Kaminsky, D Sondhi, et al.
Human Gene Therapy|November 1, 1995
Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vectorJ G Hay, N G McElvaney, J Herena, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 1996
Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosisC Danel, S C Erzurum, N G McElvaney, et al.
American Journal of Respiratory Cell and Molecular Biology|April 1, 1994
Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulationY Setoguchi, H A Jaffe, C S Chu, et al.
The American Review of Respiratory Disease|December 1, 1989
Morphologic characterization of alveolar macrophages from subjects with occupational exposure to inorganic particlesT Takemura, W N Rom, V J Ferrans, et al.
The Journal of Biological Chemistry|September 5, 1987
alpha 1-Antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exonT Nukiwa, H Takahashi, M Brantly, et al.
Schweizerische Medizinische Wochenschrift|November 24, 1998
[Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis]B M Frey, S Rafii, R G Crystal, et al.
Biochemistry|November 10, 1981
Modulation of tropoelastin production and elastin messenger ribonucleic acid activity in developing sheep lungS U Shibahara, J M Davidson, K Smith, et al.
The Journal of Clinical Investigation|April 1, 1989
Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsinD Curiel, M Brantly, E Curiel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individualsB G Harvey, N R Hackett, S Ely, et al.
Pageof 51

Showing results (171-180 of 509) with videos related to

Sort By:
Pageof 51
Current Opinion in Molecular Therapeutics|March 16, 2001
Antivector and antitransgene host responses in gene therapyN R Hackett, S M Kaminsky, D Sondhi, et al.
Human Gene Therapy|November 1, 1995
Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vectorJ G Hay, N G McElvaney, J Herena, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 1996
Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosisC Danel, S C Erzurum, N G McElvaney, et al.
American Journal of Respiratory Cell and Molecular Biology|April 1, 1994
Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulationY Setoguchi, H A Jaffe, C S Chu, et al.
The American Review of Respiratory Disease|December 1, 1989
Morphologic characterization of alveolar macrophages from subjects with occupational exposure to inorganic particlesT Takemura, W N Rom, V J Ferrans, et al.
The Journal of Biological Chemistry|September 5, 1987
alpha 1-Antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exonT Nukiwa, H Takahashi, M Brantly, et al.
Schweizerische Medizinische Wochenschrift|November 24, 1998
[Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis]B M Frey, S Rafii, R G Crystal, et al.
Biochemistry|November 10, 1981
Modulation of tropoelastin production and elastin messenger ribonucleic acid activity in developing sheep lungS U Shibahara, J M Davidson, K Smith, et al.
The Journal of Clinical Investigation|April 1, 1989
Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsinD Curiel, M Brantly, E Curiel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individualsB G Harvey, N R Hackett, S Ely, et al.
Pageof 51